FDA Import Refusal 1FX-4634930-5/10002/2 — CIPLA EU LTD
The FDA refused shipment 1FX-4634930-5/10002/2 from CIPLA EU LTD (United Kingdom) on Oct 8, 2026. The refused product falls under Drugs and Biologics — ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC). Cited charge: 75 This firm has 2 other import refusals on record.
Refusal details
- Date
- Oct 8, 2026
- Country
- United Kingdom
- Product Category
- Drugs and Biologics
- Product Code
- 61JCB08 ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC)
- Charges
- 75